Presented as part of the Musella Foundations' Brain Tumor Webinar Series. Speaker: Michael Ciesielski, PhD, Chief Executive Officer of MimiVax, LLC Presented on 7/18/23
Пікірлер: 6
@danielregufe9 ай бұрын
Hello. Is there any expectation of testing this vaccine in Brazil?
@MohaMoha-dq5qj5 ай бұрын
Hi and thanks for informative presentation. I have gbm that was diagnosed in February 2023. I had surgery followed by radiation and temozolomide for 40 days. I had a good recovery. From July to December 23 i had chemo temozolimide higher doze. But, in decemer 23 i had an mri that a recurrence and doctor prescribed avastin and irinotecan for six sessions each taken every two weeks. Tolerance has been relevatly good. My query is whether is it possible to participate in the these clinical trials after current avastin/ irinotecan?
@musellafoundation5 ай бұрын
Contact the clinical trial center closed to you and ask. If they say no, ask about expanded access.
@pw25637 ай бұрын
Can this be used just after a patient starts using Optune or is it limited to patients who just completed radiation? How does someone get accepted to clinical trial?
@jamesbelvin127111 ай бұрын
So what is the current progress with this therapy? Does it work?
@musellafoundation11 ай бұрын
It looks like it works. It is in the final stages of trials before it can apply for fda approval